Last Posted: Feb 28, 2019
- A systematic review of biomarkers to detect active tuberculosis.
MacLean Emily et al. Nature microbiology 2019 Feb - Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study.
Zürcher Kathrin et al. The Lancet. Infectious diseases 2019 Feb - Longitudinal Outbreak of Multidrug-Resistant Tuberculosis in a Hospital Setting, Serbia.
Arandjelovic Irena et al. Emerging infectious diseases 2019 Mar (3) 555-558 - Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018.
Genestet Charlotte et al. Emerging infectious diseases 2019 Mar (3) 589-592 - The Future of TB Resistance Diagnosis: The Essentials on Whole Genome Sequencing and Rapid Testing Methods.
Moreno-Molina Miguel et al. Archivos de bronconeumologia 2019 Feb - Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis.
Naidoo Anushka et al. Pharmacogenomics 2019 Feb - Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
Al-Mutairi Noura M et al. BMC infectious diseases 2019 Jan (1) 3 - World TB Day 2019
CDC, 2019 - Mycobacterium tuberculosis Next-Generation Whole Genome Sequencing: Opportunities and Challenges.
Iketleng Thato et al. Tuberculosis research and treatment 2018 20181298542 - Advances in the molecular diagnosis of tuberculosis: From probes to genomes.
Machado Diana et al. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2018 Nov
No hay comentarios:
Publicar un comentario